Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

Feb 7, 2007

29777_dirs_2007-02-06_6a9240a9-48e4-4df3-a0d5-67727f0d7b9f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-12-01

Reporting Person: DEMPSEY WILLIAM G (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-02 Common shares without par value M 39015 $41.0317 Acquired 214813 Direct
2007-02-02 Common shares without par value M 53171 $41.1069 Acquired 267984 Direct
2007-02-02 Common shares without par value M 12457 $41.6426 Acquired 280441 Direct
2007-02-02 Common shares without par value F 88697 $52.87 Disposed 191744 Direct
2006-12-01 Common shares without par value G 2553 Disposed 189191 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-02-02 Option (right to buy) $41.0317 M 39015 Disposed 2014-02-19 common shares (39015) Direct
2007-02-02 Option (right to buy) $41.1069 M 53171 Disposed 2010-02-10 common shares (53171) Direct
2007-02-02 Option (right to buy) $41.6426 M 12457 Disposed 2013-02-13 common shares (12457) Direct
2007-02-02 Option (right to buy) $52.87 A 33282 Acquired 2014-02-19 common shares (33282) Direct
2007-02-02 Option (right to buy) $52.87 A 44824 Acquired 2010-02-10 common shares (44824) Direct
2007-02-02 Option (right to buy) $52.87 A 10591 Acquired 2013-02-13 common shares (10591) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 10576 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of 2/5/07.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.